APYX Reports $12.5M Q1 Rev, $2.1M Net Loss, Raises FY2026 Rev Guidance to $59-60M, +36% YoY Surgical Aesthetics Growth, +62.9% Intl Sales Surge, Renuvion Wins 2026 NewBeauty Award
Apyx Medical Corporation Common Stock · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS · Now $3.96
+15% in 3d after detection
Post-detection moves
1h
—
1d
+3.1%
3d
+15%
7d
+8.7%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS